Metanoia Press · In preparation
Ayahuasca is a brew, not a molecule — and that is the whole point. For centuries, peoples across the northwest Amazon have combined two specific plants into a tea whose combined effect neither plant produces alone. It is one of the most sophisticated pieces of practical pharmacology in human history, worked out without a single laboratory. Our forthcoming book tells that story from both ends: the tradition that discovered it, and the chemistry that explains it.
What the Book Will Cover
Banisteriopsis caapi, the vine, and Psychotria viridis, the leaf — and the elegant chemical logic of combining them.
How the vine's beta-carbolines switch off the enzyme that would destroy the leaf's DMT — turning an inactive molecule into a hours-long journey.
Vegetalismo and the syncretic churches — Santo Daime, the União do Vegetal — and how a jungle medicine went global.
Early antidepressant findings, harmine and neuroplasticity — and the serious interaction that makes safety non-negotiable.
The brew pairs DMT (from the leaf) with beta-carbolines — harmine, harmaline, tetrahydroharmine — from the vine. Those beta-carbolines are reversible MAO inhibitors: they block the gut enzyme that normally destroys DMT, letting it reach the brain by mouth. The Indigenous "discovery" of this combination, out of tens of thousands of Amazonian plants, is one of ethnobotany's genuine marvels; Western science only understood the mechanism in the 1980s.
A placebo-controlled trial reported a rapid antidepressant effect from a single dose in treatment-resistant depression, and harmine on its own raises BDNF and promotes new neurons in the lab — connecting ayahuasca to the same neuroplasticity thread that runs through mushrooms and iboga. The controlled evidence is still limited and the sample sizes small.
Because ayahuasca contains an MAO inhibitor, combining it with common antidepressants — SSRIs and SNRIs — can trigger serotonin syndrome, a potentially dangerous reaction. This is not a soft caution; it is the pharmacological reason the traditional and clinical worlds screen so carefully. "Natural" is not the same as "safe."
Reliability: the mechanism is well established (strong); clinical antidepressant evidence is early and limited. Full sources will accompany the finished book.